Preliminary outcomes of DEB-TACE loaded with raltitrexed in the treatment of unresectable or recurrent hepatocellular carcinoma

PURPOSE: Raltitrexed shows therapeutic effects and safety in many types of malignant tumors. However, reports of the clinical outcomes of raltitrexed-based transarterial chemoembolization (TACE) or drug-eluting beads TACE (DEB-TACE) in the treatment of hepatocellular carcinoma (HCC) are rare. We aim...

Descripción completa

Detalles Bibliográficos
Autores principales: Bi, Yonghua, Wang, Yang, Zhang, Wenguang, Lu, Huibin, Ren, Jianzhuang, Han, Xinwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945722/
https://www.ncbi.nlm.nih.gov/pubmed/36814327
http://dx.doi.org/10.1186/s40644-023-00534-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9945722/
https://www.ncbi.nlm.nih.gov/pubmed/36814327
http://dx.doi.org/10.1186/s40644-023-00534-1

Ejemplares similares